Back to search results

Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Urothelial Carcinoma · Unresectable Urothelial Carcinoma · Advanced Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Pooja Ghatalia, MD) · Pooja.Ghatalia@tuhs.temple.edu
Study leads

  • Pooja Ghatalia, MD

    Principal Investigator

    Fox Chase Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)